Repare Therapeutics Inc.
RPTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $85 | $111 | $160 | $334 |
| Short-Term Investments | $68 | $112 | $184 | $7 |
| Receivables | $12 | $15 | $4 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $5 | $6 | $6 |
| Total Curr. Assets | $171 | $244 | $354 | $351 |
| Property Plant & Equip (Net) | $4 | $8 | $10 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $2 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $4 |
| Other NC Assets | $1 | $0 | $0 | $1 |
| Total NC Assets | $5 | $10 | $10 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $177 | $254 | $364 | $369 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $0 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $10 | $53 | $12 |
| Other Curr. Liab. | $20 | $24 | $22 | $19 |
| Total Curr. Liab. | $25 | $39 | $79 | $35 |
| LT Debt | $0 | $1 | $3 | $6 |
| Deferred Rev, NC | $0 | $2 | $3 | $40 |
| Deferred Tax Liab, NC | $0 | $0 | -$3 | $0 |
| Other NC Liab. | $0 | $0 | $3 | $0 |
| Total NC Liab. | $0 | $3 | $6 | $45 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $5 | $6 |
| Total Liabilities | $25 | $42 | $85 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $487 | $483 | $482 | $481 |
| Retained Earnings | -$418 | -$333 | -$239 | -$210 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $82 | $62 | $37 | $18 |
| Total Equity | $151 | $212 | $280 | $288 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $177 | $254 | $364 | $369 |
| Net Debt | -$83 | -$108 | -$154 | -$327 |